These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 16610967)

  • 21. Decreased Mitochondrial Function Among Healthy Infants Exposed to Antiretrovirals During Gestation, Delivery and the Neonatal Period.
    Noguera-Julian A; Morén C; Rovira N; Garrabou G; Catalán M; Sánchez E; Cardellach F; Miró Ó; Fortuny C
    Pediatr Infect Dis J; 2015 Dec; 34(12):1349-54. PubMed ID: 26372453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lack of evidence of mitochondrial dysfunction in the offspring of HIV-infected women. Retrospective review of perinatal exposure to antiretroviral drugs in the Perinatal AIDS Collaborative Transmission Study.
    Bulterys M; Nesheim S; Abrams EJ; Palumbo P; Farley J; Lampe M; Fowler MG;
    Ann N Y Acad Sci; 2000 Nov; 918():212-21. PubMed ID: 11131707
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transplacentally exposed human and monkey newborn infants show similar evidence of nucleoside reverse transcriptase inhibitor-induced mitochondrial toxicity.
    Divi RL; Leonard SL; Kuo MM; Nagashima K; Thamire C; St Claire MC; Wade NA; Walker VE; Poirier MC
    Environ Mol Mutagen; 2007; 48(3-4):201-9. PubMed ID: 16538687
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of new antiretrovirals on hematological toxicity in HIV-exposed uninfected infants.
    Rovira N; Noguera-Julian A; Rives S; Berrueco R; Lahoz R; Fortuny C
    Eur J Pediatr; 2016 Jul; 175(7):1013-7. PubMed ID: 27165499
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perinatal outcomes, mitochondrial toxicity and apoptosis in HIV-treated pregnant women and in-utero-exposed newborn.
    Hernàndez S; Morén C; López M; Coll O; Cardellach F; Gratacós E; Miró O; Garrabou G
    AIDS; 2012 Feb; 26(4):419-28. PubMed ID: 22156962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug safety during pregnancy and in infants. Lack of mortality related to mitochondrial dysfunction among perinatally HIV-exposed children in pediatric HIV surveillance.
    Lindegren ML; Rhodes P; Gordon L; Fleming P; ;
    Ann N Y Acad Sci; 2000 Nov; 918():222-35. PubMed ID: 11131709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systematic review of the efficacy of antiretroviral therapies for reducing the risk of mother-to-child transmission of HIV infection.
    Suksomboon N; Poolsup N; Ket-Aim S
    J Clin Pharm Ther; 2007 Jun; 32(3):293-311. PubMed ID: 17489882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Birth outcomes following zidovudine therapy in pregnant women.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1994 Jun; 43(22):409, 415-6. PubMed ID: 8003111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Congenital anomalies and in utero antiretroviral exposure in human immunodeficiency virus-exposed uninfected infants.
    Williams PL; Crain MJ; Yildirim C; Hazra R; Van Dyke RB; Rich K; Read JS; Stuard E; Rathore M; Mendez HA; Watts DH;
    JAMA Pediatr; 2015 Jan; 169(1):48-55. PubMed ID: 25383770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiretroviral exposure during pregnancy and adverse outcomes in HIV-exposed uninfected infants and children using a trigger-based design.
    Williams PL; Hazra R; Van Dyke RB; Yildirim C; Crain MJ; Seage GR; Civitello L; Ellis A; Butler L; Rich K;
    AIDS; 2016 Jan; 30(1):133-44. PubMed ID: 26731758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mitochondrial dysfunction following perinatal exposure to nucleoside analogues.
    Blanche S; Tardieu M; Benhammou V; Warszawski J; Rustin P
    AIDS; 2006 Aug; 20(13):1685-90. PubMed ID: 16931932
    [No Abstract]   [Full Text] [Related]  

  • 32. Treating HIV during pregnancy: an update on safety issues.
    Watts DH
    Drug Saf; 2006; 29(6):467-90. PubMed ID: 16752931
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV and mitochondrial toxicity in children.
    Foster C; Lyall H
    J Antimicrob Chemother; 2008 Jan; 61(1):8-12. PubMed ID: 17999978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Altered heterochromatin organization after perinatal exposure to zidovudine.
    Senda S; Blanche S; Costagliola D; Cibert C; Nigon F; Firtion G; Floch C; Parat S; Viegas-Péquignot E
    Antivir Ther; 2007; 12(2):179-87. PubMed ID: 17503660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Mitochondrial damage by antiretrovirals: diagnosis and monitoring].
    de Mendoza C; Blanco F; Soriano V
    Med Clin (Barc); 2003 Sep; 121(8):310-5. PubMed ID: 14499088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiretroviral drugs for preventing mother-to-child transmission of HIV in sub-Saharan Africa: balancing efficacy and infant toxicity.
    Ciaranello AL; Seage GR; Freedberg KA; Weinstein MC; Lockman S; Walensky RP
    AIDS; 2008 Nov; 22(17):2359-69. PubMed ID: 18981776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
    ; de Vincenzi I
    Lancet Infect Dis; 2011 Mar; 11(3):171-80. PubMed ID: 21237718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Haematological parameters of HIV-1-uninfected infants born to HIV-1-infected mothers.
    Bunders MJ; Bekker V; Scherpbier HJ; Boer K; Godfried M; Kuijpers TW
    Acta Paediatr; 2005 Nov; 94(11):1571-7. PubMed ID: 16303696
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Persistent mitochondrial dysfunction in HIV-1-exposed but uninfected infants: clinical screening in a large prospective cohort.
    Barret B; Tardieu M; Rustin P; Lacroix C; Chabrol B; Desguerre I; Dollfus C; Mayaux MJ; Blanche S;
    AIDS; 2003 Aug; 17(12):1769-85. PubMed ID: 12891063
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Growth of human immunodeficiency virus-uninfected children exposed to perinatal zidovudine for the prevention of mother-to-child human immunodeficiency virus transmission.
    Briand N; Le Coeur S; Traisathit P; Karnchanamayul V; Hansudewechakul R; Ngampiyasakul C; Bhakeecheep S; Ithisukanan J; Hongsiriwon S; McIntosh K; Lallemant M
    Pediatr Infect Dis J; 2006 Apr; 25(4):325-32. PubMed ID: 16567984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.